Linden Thomas Advisory Services, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1965702 Charlotte, NC

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,430,131

-$269,166 QoQ

Shares Held

27,150

+2.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#676

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. GILD ranks #3 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,333	$7,595,990
2	ABBV	AbbVie Inc.	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc. This page	27,150	$3,430,131
4	MRK	Merck & Co., Inc.	25,106	$3,226,121
5	AMGN	Amgen Inc	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co	30,618	$1,764,209

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,430,131	27,150	+2.3%	Shares	Sole	2026-07-16
2026-03-31	$3,699,297	26,543	-46.4%	Shares	Sole	2026-04-10
2025-12-31	$6,082,135	49,553	+2.6%	Shares	Sole	2026-01-16
2025-09-30	$5,358,414	48,274	+1.6%	Shares	Sole	2025-11-06
2025-06-30	$5,269,318	47,527	+3.6%	Shares	Sole	2025-07-31
2025-03-31	$5,142,758	45,897	+3.1%	Shares	Sole	2025-04-30
2024-12-31	$4,113,328	44,531	+3.8%	Shares	Sole	2025-01-21
2024-09-30	$3,596,819	42,901	+2.0%	Shares	Sole	2024-10-17
2024-06-30	$2,885,324	42,054	+20.3%	Shares	Sole	2024-07-10
2024-03-31	$2,561,552	34,970	+2.4%	Shares	Sole	2024-04-30
2023-12-31	$2,765,195	34,134	+6.7%	Shares	Sole	2024-02-01
2023-09-30	$2,396,656	31,981	+49.0%	Shares	Sole	2023-10-20
2023-06-30	$1,654,692	21,470	+2.8%	Shares	Sole	2023-07-27
2023-03-31	$1,732,081	20,876	+10.9%	Shares	Sole	2023-04-25
2022-12-31	$1,616,383	18,828	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.